231 related articles for article (PubMed ID: 19054515)
1. Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice.
Zhou X; Johnston TP; Johansson D; Parini P; Funa K; Svensson J; Hansson GK
Atherosclerosis; 2009 Jun; 204(2):381-7. PubMed ID: 19054515
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
3. Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia.
Khoo LH; Thiam CH; Soh SY; Angeli V
Eur J Immunol; 2015 May; 45(5):1300-12. PubMed ID: 25639537
[TBL] [Abstract][Full Text] [Related]
4. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
Johnston TP; Zhou X
J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
[TBL] [Abstract][Full Text] [Related]
6. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice.
Shibata Y; Ohata H; Yamashita M; Tsuji S; Bradfield JF; Nishiyama A; Henriksen RA; Myrvik QN
Transl Res; 2007 Feb; 149(2):62-9. PubMed ID: 17240316
[TBL] [Abstract][Full Text] [Related]
7. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
[TBL] [Abstract][Full Text] [Related]
8. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.
Zhou X; Robertson AK; Hjerpe C; Hansson GK
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):864-70. PubMed ID: 16456097
[TBL] [Abstract][Full Text] [Related]
10. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
11. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
12. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
[TBL] [Abstract][Full Text] [Related]
13. CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.
Zhong Y; Wang X; Ji Q; Mao X; Tang H; Yi G; Meng K; Yang X; Zeng Q
J Clin Immunol; 2012 Oct; 32(5):1104-17. PubMed ID: 22552859
[TBL] [Abstract][Full Text] [Related]
14. Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen.
Robertson AK; Zhou X; Strandvik B; Hansson GK
Scand J Immunol; 2004 Mar; 59(3):285-93. PubMed ID: 15030580
[TBL] [Abstract][Full Text] [Related]
15. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.
Schulte S; Sukhova GK; Libby P
Am J Pathol; 2008 Jun; 172(6):1500-8. PubMed ID: 18467709
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
17. Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels.
Bai L; Gabriels K; Wijnands E; Rousch M; Daemen MJ; Tervaert JW; Biessen EA; Heeneman S
Thromb Haemost; 2010 Jul; 104(1):143-50. PubMed ID: 20458432
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
19. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
20. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
